HIM
EGRX

Hillsdale Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Hillsdale Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33,665
Closed -$889K – 640
2022
Q3 		$889K Hold
33,665
– – 0.08% 174
2022
Q2 		$1.5M Buy
+33,665
New +$1.5M 0.12% 170